Company: ARAI
Filing Date: 2025-05-13
Form Type: S-1/A
Source: 0001641172-25-009841
Chunk: 85

Company: Arrive AI Inc.
Filing Date: 2025-05-13
Form: S-1/A
Chunk 85
---
 to certain tangible assets, the acquisition includes AirBox’s patent portfolio, which Arrive believes will broaden the capabilities of its high-tech mailbox system designed for autonomous and conventional package delivery. In addition to acquiring the above mentioned assets, AirBox’s CEO Brandon Pargoe has joined the Arrive team in the role of Vice President of Product Operations, as an independent contractor. In consideration for the asset purchase, the Company issued 94,573 shares at a price of $11.08 per share, which was determined based on the average price per stock of $11.08 issued to investors for cash in 2023 (after giving effect to the Reverse Stock Split retrospectively for all periods presented).

| 36 |

Growth Strategies

ALM mailboxes for the automated and frictionless exchange of packages and goods between people, robots, and drones are a promising new emerging market and category of technology, validated by customer interest and new competition. To obtain sustainable advantageous growth Arrive is employing proven strategies, platform thinking, and playbooks for bringing new technologies to market.

Early MarketProgress

Arrive believes an initial focus on medical operations, first on medical campuses and later growing to their extended networks for doctors, clinics, pharmacies and more, will provide a successful and profitable growth path towards more ubiquitous availability of automated delivery and pickup. Market progress:

| ● | First                                                                                                                     
 demonstration of a multi-Smart-Mailbox AP2 deployment and delivery use in partnership with USPS in Lawrence, Indiana 2022 |

| ● | Arrive                      
 AI currently has SOWs with: |

| (a) | A                                                                                                  
 F500 logistics company for delivery in 2025                                                        |
| (b) | A                                                                                                  
 Sunbelt innovation campus                                                                          |
| (c) | An                                                                                                 
 East Coast Specialty Pharma logistics company for delivery in Q4-2024 and MaaS to begin early 2025 |

| ● | Three                                                                                                                                       
 prospective Mid-west hospital chains awaiting further analysis and investigating drone flight approvals                                     |
| ● | The                                                                                                                                         
 first post-pilot MaaS production support for customers is anticipated for early 2025, which will customers to move to full-time operational 
 production and will support MaaS recurring revenue generation for Arrive AI.                                                                |
| ● | All                                                                                                                                         
 active partners and customers have executed non-disclosure agreements (NDAs).                                                               |

By focusing initially on the delivery and pickup of lab samples, medicine and supplies on medical campuses and then reaching out to their local networks of medical business partners, Arr